Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 24, 2018
A framework to rank genomic alterations as targets for cancer precision medicine: the ESMO Scale for Clinical Actionability of molecular Targets (ESCAT)J Mateo, D Chakravarty, R Dienstmann, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|January 10, 2020
Analysis of mismatch repair (MMR) proteins expression in a series of malignant pleural mesothelioma (MPM) patientsS Cedrés, S Ponce-Aix, P Iranzo, et al.
ESMO Open|April 10, 2021
Impact of COVID-19 on social media as perceived by the oncology community: results from a survey in collaboration with the European Society for Medical Oncology (ESMO) and the OncoAlert NetworkG Morgan, M Tagliamento, M Lambertini, et al.
Gynecologic Oncology|December 16, 2018
Chemotherapy and PARP inhibitors in heavily pretreated BRCA1/2 mutation ovarian cancer (BMOC) patientsV Rodriguez-Freixinos, L Fariñas-Madrid, M Gil-Martin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 14, 2021
Association of RAD51 with homologous recombination deficiency (HRD) and clinical outcomes in untreated triple-negative breast cancer (TNBC): analysis of the GeparSixto randomized clinical trialA Llop-Guevara, S Loibl, G Villacampa, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 10, 2018
Colorectal premalignancy is associated with consensus molecular subtypes 1 and 2K Chang, J A Willis, J Reumers, et al.
ESMO Open|November 7, 2025
Genomic actionability and matched targeted therapy in a decade-long institutional precision medicine program for solid tumorsR Dienstmann, A Vivancos, P Nuciforo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 29, 2017
Prediction of overall survival in stage II and III colon cancer beyond TNM system: a retrospective, pooled biomarker studyR Dienstmann, M J Mason, F A Sinicrope, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 4, 2017
Concordance of blood- and tumor-based detection of RAS mutations to guide anti-EGFR therapy in metastatic colorectal cancerJ Grasselli, E Elez, G Caratù, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 4, 2024
Recommendations for the use of next-generation sequencing (NGS) for patients with advanced cancer in 2024: a report from the ESMO Precision Medicine Working GroupM F Mosele, C B Westphalen, A Stenzinger, et al.
Pageof 3